Inventor profile of:

Stephen MARCUS

City:

Weston, Florida

Country:

United States

Published Applications:

17

Last publication date:

2022-11-10

Top Assignees for applications by Stephen MARCUS

The entities that hold a legal rights for patent applications filed by inventor MARCUS Stephen:

Recent patent applications by MARCUS Stephen

Stephen MARCUS from Weston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-11-10
US20220354882A1
Human necessities

TREATMENT OF MYELOSUPPRESSION

#2 | 2022-02-24
US20220054531A1
Human necessities

TREATMENT OF ACUTE MYELOID LEUKEMIA WITH HYPOMETHYLATING AGENTS AND 2-O, 3-O DESULFATED HEPARINOIDS

#3 | 2020-12-24
US20200397726A1
Human necessities

DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS

#4 | 2020-07-30
US20200237803A1
Human necessities

TREATMENT OF CANCERS AND HEMATOPOIETIC STEM CELL DISORDERS PRIVILEGED BY CXCL12-CXCR4 INTERACTION

#5 | 2020-02-06
US20200038431A1
Human necessities

Treatment of myelosuppression

#6 | 2020-02-06
US20200038345A1
Human necessities

Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms

#7 | 2019-01-17
US20190015443A1
Human necessities

TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH 2-O AND, OR 3-O DESULFATED HEPARINOIDS

#8 | 2018-10-18
US20180296590A1
Human necessities

TREATMENT OF MYELOSUPPRESSION

#9 | 2018-04-26
US20180110744A1
Human necessities

Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms

#10 | 2017-04-20
US20170106011A1
Human necessities

METHODS OF TREATING TRAUMATIC BRAIN INJURY AND SEQUELAE

#11 | 2017-04-06
US20170096549A1
Chemistry; metallurgy

MULTIVALENT CATION FORMULATIONS OF PARTIALLY DESULFATED HEPARINS

#12 | 2016-08-25
US20160243168A1
Human necessities

ADOPTIVE CELL TRANSFER METHODS

#13 | 2016-08-18
US20160235779A1
Human necessities

Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids

#14 | 2016-07-28
US20160213706A1
Human necessities

TREATMENT OF MYELOSUPPRESSION

#15 | 2013-12-05
US20130323230A1
Human necessities

Treatment of myelosuppression

#16 | 2013-11-14
US20130303481A1
Human necessities

Treatment of myelosuppression

#17 | 2012-08-02
US20120196828A1
Human necessities

SENSITIZATION OF CANCER CELLS TO TREATMENT

InventorID:

530016 ⎘